Bio Pharma Services, Inc. Acquires Key Intellectual Property and Human Resource Assets of Bioanalytical Laboratory Services (BLS)

Bio Pharma Services, Inc. Acquires Key Intellectual Property and Human Resource Assets of Bioanalytical Laboratory Services (BLS).

 Toronto, Canada – Bio Pharma Services, Inc. (Bio Pharma) is proud to announce that it has acquired key human resource assets along with a list of validated assays from Bioanalytical Laboratory Services (BLS). Over the past 3 years, BLS, led by Lab Director, Nicola Hughes, Ph.D., has built a leading bioanalytical research centre specializing in complex method development, method validation and the analysis of biological samples for pre-clinical and clinical drug trials (BA/BE studies). BLS assets will be combined with Bio Pharma’s existing Bioanalytical Lab to further expand and fortify its analytical services and become a global leader in clinical research.

“We are very proud to combine the best of Bio Pharma’s existing bioanalytical lab with the best of BLS. Under the scientific leadership of Dr. Hughes, the expanded lab at Bio Pharma will be able to immediately offer challenging and complex new assays while strengthening our Scientific R&D team. This is just one  of a list of benefits associated with merging the assets of two great labs at Bio Pharma.” said Renzo DiCarlo, CEO at Bio Pharma Services, Inc.

Effective immediately, Dr. Hughes will be appointed to the Bio Pharma Executive Team as the Vice- President of Lab Operations. “I am extremely excited about my team joining the Bio Pharma team and believe together, by offering scientific excellence, high quality assays and our commitment to providing exceptional service to our clients, we are ideally suited for the early stage research market.”

With this news, existing BLS client projects will be honoured and completed as planned at the current BLS facility. Anna Taylor, Vice-President of Business Development reiterated, “We truly are a client centered organization driven by science and quality research. I am excited that we have this opportunity to share our expanded BA lab expertise and service for both past and future clients under this new team at Bio Pharma.”

The statements in this press release are solely expressed and made by Bio Pharma Services, Inc.

 
About Bio Pharma Services Inc.

Bio Pharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa and Bioequivalence clinical trials for international pharmaceutical companies worldwide. Bio Pharma has clinical facilities both in the USA and Canada with a total capacity of 250 beds with access to healthy volunteers, special populations and patients. Headquartered in Toronto, Canada, Bio Pharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis, Medical Writing and Data Management.

 
About Bioanalytical Laboratory Services (“BLS”)

Bioanalytical Laboratory Services is a Contract Research Organization (“CRO”) that specializes in the development, validation and application of LC-MS/MS bioanalytical methods for pre-clinical, non-clinical, Phase 1, and BA/BE clinical trials. The business employs a team who service clinical CROs and generic drug manufactures from BLS’ Toronto based laboratory.

 
For more information regarding this press release, please contact Ms. Anna Taylor, Vice President, Business Development at ataylor@biopharmaservices.com